Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy
AXONE-Acute
AXONE -Acute : Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy
1 other identifier
interventional
20
1 country
4
Brief Summary
Pilot study to evaluate the performance of a lead below 2 French with specific distal shape to deliver efficient LV pacing
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
Shorter than P25 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2018
CompletedStudy Start
First participant enrolled
August 8, 2018
CompletedFirst Posted
Study publicly available on registry
November 21, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 13, 2018
CompletedApril 20, 2026
February 1, 2019
4 months
July 27, 2018
April 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
LV Multizone pacing success rate
Percent of patients where the placement of the AXONE lead provides two distant LV pacing vectors matching Pacing Threshold ≤ 3.5V/0.5ms
20 min
LV pacing success rate
Percent of patients where the placement of the AXONE lead allows at least one LV pacing vector matching Pacing Threshold ≤ 3.5V/0.5ms
20 min
Secondary Outcomes (6)
Implant testing Procedure-related Adverse Events procedure.
1 month post testing
Electrical performance of device (1)
20 min
Electrical performance of device (2)
20 min
Lead Implant Efficiency
20 min
Lead Implant Efficiency
20 min
- +1 more secondary outcomes
Study Arms (1)
Implant test procedure
EXPERIMENTALImplant test procedure with new LV quadripolar lead before a standard implantation for Cardiac resynchronisation therapy
Interventions
Implant test procedure with new LV quadripolar lead before a standard implantation for Cardiac resynchronisation therapy
Eligibility Criteria
You may qualify if:
- Male or female patient aged ≥18 years old.
- Patient presenting a CRT-P or CRT-D indication according to the latest ESC guidelines .
- Primary implant of a CRT device (including upgrade from a single or dual-chamber pacemaker or ICD).
- Signed and dated informed consent.
- Patient affiliated with, or beneficiary of a social security category.
You may not qualify if:
- Class IV of NYHA (ambulatory or not).
- Allergy to contrast media used for imaging during cardiac catheterization.
- Severe Renal Failure (clearance of creatinine \< 30ml/mn/m²).
- Previous failure catheterization of the coronary sinus, or previous failure of left ventricular lead implantation.
- Already included in another clinical study involving intra-cardiac active implantable device, or participation to any other clinical trial in the last 2 weeks.
- Person deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision).
- Known pregnancy, breastfeeding women or in childbearing age without an adequate contraceptive method (failure rate \< 1%).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Rouenlead
- MicroPort CRMcollaborator
Study Sites (4)
Bordeaux University Hospital
Bordeaux, France
Lille University Hospital
Lille, France
Rennes University Hospital
Rennes, France
Rouen University Hospital
Rouen, France
Related Publications (1)
Anselme F, Albatat M, Marquie C, Leclercq C, Ritter P, Ollivier JF, Shan N, Ziglio F, Feuerstein D. Exploring a New Systematic Route for Left Ventricular Pacing in Cardiac Resynchronization Therapy. Circ J. 2021 Feb 25;85(3):283-290. doi: 10.1253/circj.CJ-20-0266. Epub 2021 Jan 27.
PMID: 33504741RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Frédéric ANSELME, Pr
University Hospital, Rouen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2018
First Posted
November 21, 2018
Study Start
August 8, 2018
Primary Completion
December 13, 2018
Study Completion
December 13, 2018
Last Updated
April 20, 2026
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share